nitroaspirin has been researched along with ncx 4040 in 7 studies
| Studies (nitroaspirin) | Trials (nitroaspirin) | Recent Studies (post-2010) (nitroaspirin) | Studies (ncx 4040) | Trials (ncx 4040) | Recent Studies (post-2010) (ncx 4040) |
|---|---|---|---|---|---|
| 127 | 9 | 8 | 24 | 0 | 11 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bos, C; de Esch, IJ; Hulsman, N; Jongejan, A; Leurs, R; Medema, JP; Richel, D; Smit, MJ; Wijtmans, M | 1 |
| Angelini, G; Jeremy, JY; Muzaffar, S; Shukla, N | 1 |
| Amadori, D; Bolla, M; Brigliadori, G; Fabbri, F; Rosetti, M; Tesei, A; Ulivi, P; Vannini, I; Zoli, W | 1 |
| Chandrasena, RE; Dunlap, T; Sinha, V; Thatcher, GR; Wang, Z | 1 |
| Bobko, A; Bratasz, A; Ignarro, LJ; Khramtsov, VV; Kuppusamy, P; Selvendiran, K; Wasowicz, T | 1 |
| Balint, B; Bufan, B; Colić, M; Mojsilović, S; Vasilijić, S; Vucević, D; Vucićević, D | 1 |
| Delgadillo, D; Duarte, LF; Fernández-Ramires, R; Fernández-Soto, R; Jara, JA; Madariaga-Venegas, F; Molina-Berríos, A; Suarez, N; Urzúa, B | 1 |
7 other study(ies) available for nitroaspirin and ncx 4040
| Article | Year |
|---|---|
Chemical insights in the concept of hybrid drugs: the antitumor effect of nitric oxide-donating aspirin involves a quinone methide but not nitric oxide nor aspirin.
Topics: Antineoplastic Agents; Apoptosis; Aspirin; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Indolequinones; Magnetic Resonance Spectroscopy; Nitric Oxide; Nitric Oxide Donors; Structure-Activity Relationship | 2007 |
Nitroaspirins and morpholinosydnonimine but not aspirin inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Evaluation, Preclinical; Endothelial Cells; Endothelium, Vascular; Enzyme Induction; Epoprostenol; Glycoproteins; Guanylate Cyclase; Interleukin-1; Lipopolysaccharides; Male; Molsidomine; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Nitric Oxide; Nitric Oxide Donors; Nitro Compounds; Onium Compounds; Pulmonary Artery; Respiratory Distress Syndrome; Superoxides; Sus scrofa; Tumor Necrosis Factor-alpha | 2004 |
Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Caspase 9; Cell Cycle; Cell Line, Tumor; Cytotoxins; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Nitric Oxide Donors; Nitro Compounds; Pancreatic Neoplasms; S-Nitroso-N-Acetylpenicillamine; Salicylates | 2006 |
Quinone formation as a chemoprevention strategy for hybrid drugs: balancing cytotoxicity and cytoprotection.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzoquinones; Catalysis; Cell Line, Tumor; Cell Survival; Chemoprevention; Cytoprotection; Esterases; Glutathione; Liver; Luciferases; Metabolic Detoxication, Phase II; Mice; Models, Biological; NAD(P)H Dehydrogenase (Quinone); NADPH Dehydrogenase; Nitro Compounds; Response Elements; Swine | 2007 |
NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.
Topics: Animals; Antineoplastic Agents; Aspirin; Cell Line, Tumor; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Mice; Mice, Nude; Molecular Structure; Nitro Compounds; Ovarian Neoplasms; Sensitivity and Specificity; Statistics as Topic; Sulfhydryl Compounds; Xenograft Model Antitumor Assays | 2008 |
Comparative effects of aspirin and NO-releasing aspirins on differentiation, maturation and function of human monocyte-derived dendritic cells in vitro.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antigens, Differentiation; Apoptosis; Aspirin; Cell Differentiation; Cells, Cultured; Dendritic Cells; Down-Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-10; Interleukin-12 Subunit p40; Interleukin-4; Lipopolysaccharides; Lymphocyte Activation; Monocytes; Nitric Oxide; Nitro Compounds | 2009 |
Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients.
Topics: Antifungal Agents; Aspirin; Bacterial Adhesion; Biofilms; Candida albicans; Dinoprostone; Drug Resistance, Fungal; Fluconazole; Free Radical Scavengers; Humans; Inhibitory Concentration 50; Microbial Viability; Nitro Compounds; Stomatitis, Denture | 2017 |